Drawing for AMICORE

USPTO serial 87377421

AMICORE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BLACK, MILDRED ELIZABETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AMICORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lee J. Eulgen

LEE J. EULGEN NEAL GERBER & EISENBERG LLPTWO NORTH LASALLE STREETCHICAGO, IL 60602UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009apparatus for recording, transmission, processing and reproduction of dataACTIVE—
010apheretic apparatus and instruments for withdrawing whole blood, separating its components and returning the remaining blood to the donor or patient; apparatus and instruments for separating the components of bodily fluids for medical purposes; apheretic apparatus and instruments consisting primarily of plastic tubing and containers all sold as components of apheretic kits for withdrawing whole blood, separating its components and returning the remaining blood to the donor or patient; apparatus and instruments for separating the components of bodily fluids consisting of plastic tubing and containers all sold as components of apheretic kits for withdrawing whole blood, separating its components and returning the remaining blood to the donor or patient for medical purposes; medical apparatus and instruments for testing and treating blood; surgical and medical apparatus and instruments for withdrawing whole blood, separating its components and returning the remaining blood to the donor or patient; skins for medical apparatus and instruments, namely, protective coverings specially adapted for enclosing and/or sealing medical instruments; replacement parts for all of the aforesaid goodsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 19, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 19, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 22, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 20, 2018EX1GSOU EXTENSION 1 GRANTED—
Mar 20, 2018EXT1SOU EXTENSION 1 FILED—
Mar 20, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 17, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 22, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 22, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 2, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 11, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 29, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 29, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 29, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 19, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 19, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 19, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2017DOCKASSIGNED TO EXAMINER—
Mar 23, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 23, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance